| Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma S Mithraprabhu, A Kalff, A Chow, T Khong, A Spencer Epigenetics 9 (11), 1511-1520, 2014 | 180 | 2014 |
| Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma S Mithraprabhu, T Khong, M Ramachandran, A Chow, D Klarica, L Mai, ... Leukemia 31 (8), 1695-1705, 2017 | 122 | 2017 |
| Expression of c-Kit receptor mRNA and protein in the developing, adult and irradiated rodent testis SM Prabhu, ML Meistrich, EA McLaughlin, SD Roman, S Warne, ... Reproduction 131 (3), 489-499, 2006 | 102 | 2006 |
| Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome P Tan, A Wei, S Mithraprabhu, N Cummings, HB Liu, M Perugini, K Reed, ... Blood cancer journal 4 (1), e170-e170, 2014 | 99 | 2014 |
| Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo S Mithraprabhu, S Mendis, SJ Meachem, L Tubino, MM Matzuk, ... Biology of reproduction 82 (5), 980-990, 2010 | 76 | 2010 |
| Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients S Mithraprabhu, R Morley, T Khong, A Kalff, K Bergin, J Hocking, ... Leukemia 33 (8), 2022-2033, 2019 | 63 | 2019 |
| Control of KIT signalling in male germ cells: what can we learn from other systems? S Mithraprabhu, KL Loveland Reproduction 138 (5), 743, 2009 | 58 | 2009 |
| Expression of nuclear transport importins beta 1 and beta 3 is regulated during rodent spermatogenesis KL Loveland, C Hogarth, A Szczepny, SM Prabhu, DA Jans Biology of reproduction 74 (1), 67-74, 2006 | 57 | 2006 |
| Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies J Hocking, S Mithraprabhu, A Kalff, A Spencer Cancer biology & medicine 13 (2), 215, 2016 | 47 | 2016 |
| Male age is associated with sperm DNA/chromatin integrity AD Mettler, M Govindarajan, S Srinivas, S Mithraprabhu, D Evenson, ... The Aging Male, 2019 | 43 | 2019 |
| Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC. S Mithraprabhu, T Khong, SS Jones, A Spencer British journal of haematology 162 (4), 2013 | 43 | 2013 |
| Circulating tumour DNA analysis for tumour genome characterisation and monitoring disease burden in extramedullary multiple myeloma S Mithraprabhu, S Sirdesai, M Chen, T Khong, A Spencer International Journal of Molecular Sciences 19 (7), 1858, 2018 | 38 | 2018 |
| Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton S Mithraprabhu, T Khong, A Spencer Cell Death & Disease 5 (3), e1134-e1134, 2014 | 30 | 2014 |
| TCam‐2 seminoma cell line exhibits characteristic foetal germ cell responses to TGF‐beta ligands and retinoic acid JC Young, A Jaiprakash, S Mithraprabhu, C Itman, R Kitazawa, ... International journal of andrology 34 (4pt2), e204-e217, 2011 | 30 | 2011 |
| Utility of circulating cell-free RNA analysis for the characterization of global transcriptome profiles of multiple myeloma patients M Chen, S Mithraprabhu, M Ramachandran, K Choi, T Khong, A Spencer Cancers 11 (6), 887, 2019 | 25 | 2019 |
| Deactylase inhibition in myeloproliferative neoplasms S Mithraprabhu, G Grigoriadis, T Khong, A Spencer Investigational new drugs 28, 50-57, 2010 | 25 | 2010 |
| Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders S Mithraprabhu, M Chen, I Savvidou, A Reale, A Spencer Leukemia 35 (10), 2771-2783, 2021 | 23 | 2021 |
| Mining the plasma cell transcriptome for novel cell surface proteins S Trezise, A Karnowski, PL Fedele, S Mithraprabhu, Y Liao, K D’costa, ... International Journal of Molecular Sciences 19 (8), 2161, 2018 | 22 | 2018 |
| DNA-repair gene mutations are highly prevalent in circulating tumour DNA from multiple myeloma patients S Mithraprabhu, J Hocking, M Ramachandran, K Choi, D Klarica, T Khong, ... Cancers 11 (7), 917, 2019 | 19 | 2019 |
| Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study) A Kalff, T Khong, S Mithraprabhu, K Bergin, J Reynolds, KM Bowen, ... Leukemia & lymphoma, 2019 | 17 | 2019 |
